QSAM Biosciences, Inc.

📍 Austin, United States🗓 Founded 2020👥 5 employees💰 Last funded Aug 2020
Biotechnology Research🌐 qsambio.com
Website LinkedIn
QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in QSAM Biosciences, Inc.?
QSAM Biosciences, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did QSAM Biosciences, Inc. last raise funding?
The most recent investment in QSAM Biosciences, Inc. recorded on gritt.io was in August 2020.
When was QSAM Biosciences, Inc. founded?
QSAM Biosciences, Inc. was founded in 2020.
What industry is QSAM Biosciences, Inc. in?
QSAM Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is QSAM Biosciences, Inc. based?
QSAM Biosciences, Inc. is headquartered in Austin, United States.